Skip to content

Analgesic effect of indwelling PENG block

Postoperative analgesic effect of indwelling PENG block catheter

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1031240230
Enrollment
30
Registered
2024-07-24
Start date
2025-01-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral neck fractures, idiopathic femoral head necrosis, osteoarthritis of the hip

Interventions

To compare the clinical efficacy of PENG block and continuous catheter analgesia after orthopedic hip surgery versus a single PENG block group.

Sponsors

NAKAZAWA KEISUKE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults 20 years of age or older 2) Patients with BMI between 18.5 and 25.0 kg/m2 3) Patients with American Society of Anesthesiologists Preanesthetic Risk Assessment (ASA-PS)3 or less (ASA-PS Classification 1: No organic, biochemical, or psychiatric abnormalities. Classification 2: Mild to moderate systematic disorder. Classification 3: Severe systematic disorder. Classification 4: Severe systemic disorders that are life-threatening and cannot be cured by surgery. Classification 5: Dying.) 4) Persons who give written consent to participate in the research.

Exclusion criteria

Exclusion criteria: 1) Patients who do not meet the above selection criteria 2) Patients allergic to amide-type local anesthetics 3) Patients on anticoagulation therapy with PT-INR (Prothrombin Time International Normalized Ratio) >1.2 or on dual anti-platelet therapy (DAPT: Dual Anti-platelet therapy).(DAPT: Dual Anti-platelet therapy), excluding biazpirin monotherapy and prophylactic low molecular weight heparin therapy.DAPT (Dual Anti-platelet Therapy), excluding biazpirin monotherapy and prophylactic low molecular weight heparin therapy 4) Patients with any of the contraindications listed in the package insert. 5) Patients with moderate to severe hepatic dysfunction 6) Patients with arrhythmia requiring pacemaker insertion 7) Patients who meet all of the "selection criteria" and none of the "exclusion criteria" among the above-mentioned eligible patients. 7) Patients who meet all of the above selection criteria and none of the exclusion criteria. 8) Patients who have refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Pain score (VAS scale: Visual Analogue Scale or NRS: Numerical rating scale) at 0, 2, 6, 12 (before sleep and after waking), 24, and 24 hours after surgery.

Secondary

MeasureTime frame
Number of cases requiring additional rescue analgesia (NSAIDs, weak opioid analgesics) prescribed on the ward postoperatively and the time since surgery for which the additional analgesia was requested; presence of PONV (postoperative nausea and vomiting); vital signs (max/min/average blood pressure, respiratory rate, pulse rate) upon leaving the operating room; degree of muscle weakness by manual leg muscle strength degree of muscle weakness by lower leg manual muscle strength test. Time (in days) to rehabilitation ambulation. Number of days in hospital. Presence or absence of postoperative delirium. Presence or absence of sleep disturbance.

Contacts

Public ContactKeisuke Nakazawa

Nihon University School of Medicine Itabashi Hospital

nakazawa.keisuke@nihon-u.ac.jp+81-339728111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026